Literature DB >> 12874389

Chronic daily headache: is analgesic overuse a cause or a consequence?

Richard B Lipton, Marcelo E Bigal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12874389     DOI: 10.1212/wnl.61.2.154

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  11 in total

Review 1.  Medication overuse headache in patients with primary headache disorders: epidemiology, management and pathogenesis.

Authors:  Andrew J Dowson; David W Dodick; Volker Limmroth
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 2.  Chronic migraine: epidemiology and disease burden.

Authors:  Aubrey N Manack; Dawn C Buse; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2011-02

3.  OnabotulinumtoxinA in chronic migraine: is the response dose dependent?

Authors:  Ali Zandieh; Fred Michael Cutrer
Journal:  BMC Neurol       Date:  2022-06-13       Impact factor: 2.903

4.  Self-help group and medication overuse headache: preliminary data.

Authors:  Elisa Sancisi; Marialuisa Rausa; Stefano Zanigni; Sabina Cevoli; Andrea Norcini Pala; Marianna Nicodemo; Daniela Grimaldi; Pasquale Montagna; Pietro Cortelli; Giulia Pierangeli
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

5.  Prevalence of migraine and tension-type headache among adults in Jordan.

Authors:  Karem H Alzoubi; Nizar Mhaidat; Sayer Al Azzam; Yousef Khader; Saad Salem; Hanin Issaifan; Rania Haddadin
Journal:  J Headache Pain       Date:  2009-04-23       Impact factor: 7.277

6.  Polymorphism of the Glutamate Transporter Protein EAAT2 and Migraine Transformation into Chronic Daily Headache.

Authors:  Hae-Eun Shin; Soo-Jeong Han; Kwang-Soo Lee; Jeong-Wook Park
Journal:  J Clin Neurol       Date:  2011-09-29       Impact factor: 3.077

7.  Prophylactic onabotulinumtoxinA in patients with chronic migraine and comorbid depression: An open-label, multicenter, pilot study of efficacy, safety and effect on headache-related disability, depression, and anxiety.

Authors:  Guy P Boudreau; Brian M Grosberg; Peter J McAllister; Richard B Lipton; Dawn C Buse
Journal:  Int J Gen Med       Date:  2015-02-18

8.  Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): a randomized, monocentric clinical trial.

Authors:  Andreas Straube; J Ellrich; O Eren; B Blum; R Ruscheweyh
Journal:  J Headache Pain       Date:  2015-07-09       Impact factor: 7.277

9.  Cost impact of a non-invasive, portable device for patient self-administration of chronic migraine in a UK National Health Service setting.

Authors:  B Brüggenjürgen; T Baker; R Bhogal; F Ahmed
Journal:  Springerplus       Date:  2016-08-03

10.  Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

Authors:  Modar Khalil; Hassan W Zafar; Victoria Quarshie; Fayyaz Ahmed
Journal:  J Headache Pain       Date:  2014-09-01       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.